• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    PDD Posts Upbeat Revenue, Joins Avidity Biosciences, SpringWorks Therapeutics And Other Big Stocks Moving Higher On Tuesday

    11/28/23 9:39:07 AM ET
    $CG
    $CWEN
    $GDEV
    $LASR
    Investment Managers
    Finance
    Electric Utilities: Central
    Utilities
    Get the next $CG alert in real time by email

    U.S. stocks traded mixed, with the Dow Jones gaining around 10 points on Tuesday.

    Shares of PDD Holdings Inc. (NASDAQ:PDD) shares jumped in Tuesday’s session following third-quarter results.
    PDD reported third-quarter FY23 revenue growth of 94% year-on-year to $9.44 billion, beating the consensus of $7.69 billion.The Chinese online retailer's adjusted earnings per ADS of RMB11.61 ($1.55), compared with RMB8.62 Y/Y, beating the consensus of $1.23.

    PDD Holdings shares jumped 18.6% to $139.62 on Tuesday.

    Here are some other big stocks recording gains in today’s session.

    • Avidity Biosciences, Inc. (NASDAQ:RNA) surged 22.3% to $7.53 after the company reported expansion of cardiovascular collaboration with Bristol Myers Squibb.
    • SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) gained 15.5% to $23.99. The FDA approved SpringWorks Therapeutics’ Ogsiveo (nirogacestat), an oral gamma-secretase inhibitor, for adult patients with progressing desmoid tumors who require systemic treatment.
    • GDEV Inc. (NASDAQ:GDEV) surged 10% to $2.53. The company recently reported a decline in third-quarter sales.
    • nLIGHT, Inc. (NASDAQ:LASR) gained 8% to $13.98. Benchmark upgraded nLight from Hold to Speculative Buy and announced a $17 price target.
    • Clearway Energy, Inc. (NYSE:CWEN) gained 7.4% to $24.55. Clearway Energy will replace Veritiv in the S&P SmallCap 600.
    • The Carlyle Group Inc. (NASDAQ:CG) rose 6% to $34.78. Carlyle Group will replace ICU Medical in the S&P MidCap 400, effective prior to the open of trading on Nov. 30.
    • LendingClub Corporation (NYSE:LC) gained 5.4% to $5.88. Piper Sandler initiated coverage on LendingClub with an Overweight rating and announced a price target of $8.

     

    Now Read This: Boeing To Rally More Than 25%? Here Are 10 Top Analyst Forecasts For Tuesday

    Get the next $CG alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CG
    $CWEN
    $GDEV
    $LASR

    CompanyDatePrice TargetRatingAnalyst
    nLIGHT Inc.
    $LASR
    3/27/2026Outperform
    William Blair
    PDD Holdings Inc.
    $PDD
    3/27/2026$136.00Neutral → Buy
    Nomura
    Atrium Therapeutics Inc.
    $RNA
    3/11/2026$25.00Overweight
    Wells Fargo
    nLIGHT Inc.
    $LASR
    3/4/2026Outperform
    Robert W. Baird
    The Carlyle Group Inc.
    $CG
    2/24/2026$67.00Outperform
    RBC Capital Mkts
    nLIGHT Inc.
    $LASR
    1/20/2026$60.00Buy
    Stifel
    Clearway Energy Inc.
    $CWEN
    12/17/2025$38.00Neutral → Sector Outperform
    CIBC
    The Carlyle Group Inc.
    $CG
    12/11/2025$74.00Buy
    UBS
    More analyst ratings

    $CG
    $CWEN
    $GDEV
    $LASR
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    November 27, 2023 - FDA Approves First Therapy for Rare Type of Non-Cancerous Tumors

    For Immediate Release: November 27, 2023 Today, the U.S. Food and Drug Administration approved Ogsiveo (nirogacestat) tablets for adult patients with progressing desmoid tumors who require systemic treatment. Ogsiveo is the first drug to be approved for the treatment of patients with desmoid tumors, a rare subtype of soft tissue sarcomas. Desmoid tumors are non-cancerous but can be locally aggressive. The tumor

    11/27/23 5:34:21 PM ET
    $SWTX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    FDA Approval for OGSIVEO issued to SPRINGWORKS THERAPEUTICS INC

    Submission status for SPRINGWORKS THERAPEUTICS INC's drug OGSIVEO (ORIG-1) with active ingredient NIROGACESTAT has changed to 'Approval' on 11/27/2023. Application Category: NDA, Application Number: 217677, Application Classification: Type 1 - New Molecular Entity

    11/27/23 5:34:04 PM ET
    $SWTX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $CG
    $CWEN
    $GDEV
    $LASR
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Fengate acquires interest in operational U.S. solar portfolio

    Houston, TX, March 31, 2026 (GLOBE NEWSWIRE) -- Fengate Asset Management (Fengate) is pleased to announce the acquisition of a 50% interest in a 227 MWac portfolio of 12 operating solar projects in the western United States. The investment is a 50/50 joint-venture with independent power producer, Clearway Energy Inc. (NYSE:CWEN), an existing investment partner of Fengate's on an operational wind facility. "This transaction supports our energy transition strategy to acquire core, operating long-term contracted renewable projects for Fengate Infrastructure Yield Fund, and we are proud to partner with Clearway on a second renewables investment," said Greg Calhoun, Managing Director an

    3/31/26 9:00:00 AM ET
    $CWEN
    Electric Utilities: Central
    Utilities

    Carlyle to Acquire Majority Stake in MAI Capital Management

    The new investment strengthens MAI's capital base, supports advisors, and provides continuity for clients and teams MAI Capital Management ("MAI"), a registered investment advisor ("RIA") focused on empowering clients to simplify, protect, and grow their wealth, today announced that it has signed an agreement for funds managed by global investment firm Carlyle (NASDAQ:CG) to acquire a majority stake in the company, valuing it at more than $2.8 billion. Carlyle initially invested in MAI in 2021 through its investment in Galway Holdings, which acquired MAI that year, and will become the majority owner upon closing, with Galway Holdings, funds managed by Harvest Partners, LP ("Harvest Partne

    3/31/26 7:30:00 AM ET
    $CG
    Investment Managers
    Finance

    Acentra Health Names New Senior Vice Presidents, Mohamed Karama and Nirav Dalal, to Drive Company Growth and Business Development

    MCLEAN, Va., March 25, 2026 (GLOBE NEWSWIRE) -- Acentra Health, a technology and health solutions and services company dedicated to accelerating better outcomes for its government and commercial healthcare clients and the populations they serve, announced today that Mohamed Karama has joined the company as Senior Vice President of Growth Acceleration and Performance, and Nirav Dalal has been promoted to Senior Vice President of Sales Leadership. These appointments advance Acentra Health's transformation initiatives and position the company for strategic growth. "As we continue transforming Acentra Health, we're investing in our growth engine," said Patty Obermaier, EVP, Chief Growth Offic

    3/25/26 9:33:00 AM ET
    $CG
    Investment Managers
    Finance

    $CG
    $CWEN
    $GDEV
    $LASR
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Accounting Officer Nias James bought $10,400 worth of shares (1,173 units at $8.87) and sold $15,249 worth of shares (1,173 units at $13.00) (SEC Form 4)

    4 - NLIGHT, INC. (0001124796) (Issuer)

    5/22/25 7:27:46 PM ET
    $LASR
    Semiconductors
    Technology

    Director Zeisser Michael P bought $187,000 worth of shares (20,000 units at $9.35), increasing direct ownership by 13% to 174,138 units (SEC Form 4)

    4 - LendingClub Corp (0001409970) (Issuer)

    5/2/25 6:18:00 PM ET
    $LC
    Finance: Consumer Services
    Finance

    Director Zeisser Michael P bought $257,600 worth of shares (20,000 units at $12.88), increasing direct ownership by 16% to 148,018 units (SEC Form 4)

    4 - LendingClub Corp (0001409970) (Issuer)

    2/5/25 5:59:52 PM ET
    $LC
    Finance: Consumer Services
    Finance

    $CG
    $CWEN
    $GDEV
    $LASR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    $CG
    $CWEN
    $GDEV
    $LASR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    $CG
    $CWEN
    $GDEV
    $LASR
    SEC Filings

    View All

    SEC Form 4 filed by Totalenergies Se

    4 - Clearway Energy, Inc. (0001567683) (Issuer)

    4/2/26 6:49:34 PM ET
    $CWEN
    Electric Utilities: Central
    Utilities

    SEC Form 4 filed by Blackrock Portfolio Management Llc

    4 - Clearway Energy, Inc. (0001567683) (Issuer)

    4/2/26 6:33:00 PM ET
    $CWEN
    Electric Utilities: Central
    Utilities

    SEC Form 4 filed by Rietjens Ivonne Mcm

    4 - PDD Holdings Inc. (0001737806) (Issuer)

    4/1/26 7:39:32 AM ET
    $PDD
    EDP Services
    Technology

    William Blair initiated coverage on nLIGHT

    William Blair initiated coverage of nLIGHT with a rating of Outperform

    3/27/26 8:51:35 AM ET
    $LASR
    Semiconductors
    Technology

    PDD Holdings upgraded by Nomura with a new price target

    Nomura upgraded PDD Holdings from Neutral to Buy and set a new price target of $136.00

    3/27/26 8:43:00 AM ET
    $PDD
    EDP Services
    Technology

    Wells Fargo initiated coverage on Atrium Therapeutics with a new price target

    Wells Fargo initiated coverage of Atrium Therapeutics with a rating of Overweight and set a new price target of $25.00

    3/11/26 8:36:38 AM ET
    $RNA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SCHEDULE 13D/A filed by Clearway Energy Inc.

    SCHEDULE 13D/A - Clearway Energy, Inc. (0001567683) (Subject)

    4/3/26 4:55:19 PM ET
    $CWEN
    Electric Utilities: Central
    Utilities

    Clearway Energy Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits

    8-K - Clearway Energy, Inc. (0001567683) (Filer)

    4/1/26 9:28:04 PM ET
    $CWEN
    Electric Utilities: Central
    Utilities

    SEC Form 20-F filed by GDEV Inc.

    20-F - GDEV Inc. (0001848739) (Filer)

    3/31/26 4:50:38 PM ET
    $GDEV
    EDP Services
    Technology

    $CG
    $CWEN
    $GDEV
    $LASR
    Leadership Updates

    Live Leadership Updates

    View All

    Acentra Health Names New Senior Vice Presidents, Mohamed Karama and Nirav Dalal, to Drive Company Growth and Business Development

    MCLEAN, Va., March 25, 2026 (GLOBE NEWSWIRE) -- Acentra Health, a technology and health solutions and services company dedicated to accelerating better outcomes for its government and commercial healthcare clients and the populations they serve, announced today that Mohamed Karama has joined the company as Senior Vice President of Growth Acceleration and Performance, and Nirav Dalal has been promoted to Senior Vice President of Sales Leadership. These appointments advance Acentra Health's transformation initiatives and position the company for strategic growth. "As we continue transforming Acentra Health, we're investing in our growth engine," said Patty Obermaier, EVP, Chief Growth Offic

    3/25/26 9:33:00 AM ET
    $CG
    Investment Managers
    Finance

    Carlyle to Host 2026 Shareholder Update

    WASHINGTON and NEW YORK, Feb. 02, 2026 (GLOBE NEWSWIRE) -- Global investment firm Carlyle (NASDAQ:CG) announced today that it will host a Shareholder Update on Thursday, February 26, 2026. The Shareholder Update will include a series of presentations by the company's senior leadership team and will review Carlyle's growth outlook and financial objectives. Presentations will begin at 8:30 a.m. EST, followed by a Q&A session. Presentation materials and a live webcast will be posted on the day of the event and can be accessed on the Events & Presentations section of ir.carlyle.com. For those unable to join the live webcast, a replay will be available on the website following the event. Any

    2/2/26 8:01:00 AM ET
    $CG
    Investment Managers
    Finance

    Acentra Health Appoints Balajee Sethuraman as Executive Vice President and Chief Business Services Officer

    MCLEAN, Va., Jan. 27, 2026 (GLOBE NEWSWIRE) -- Acentra Health, a technology and health solutions company dedicated to accelerating better health outcomes for government and commercial clients and the populations they serve, today announced the appointment of Balajee Sethuraman as Executive Vice President and Chief Business Services Officer (CBSO), where he will lead the company's business services and delivery operations. This strategic addition to Acentra Health's executive leadership team supports its ongoing efforts to streamline and strengthen enterprise-wide delivery through a unified operating model. "Balajee is a transformative leader with exceptional experience scaling global team

    1/27/26 9:33:00 AM ET
    $CG
    Investment Managers
    Finance

    $CG
    $CWEN
    $GDEV
    $LASR
    Financials

    Live finance-specific insights

    View All

    Fengate acquires interest in operational U.S. solar portfolio

    Houston, TX, March 31, 2026 (GLOBE NEWSWIRE) -- Fengate Asset Management (Fengate) is pleased to announce the acquisition of a 50% interest in a 227 MWac portfolio of 12 operating solar projects in the western United States. The investment is a 50/50 joint-venture with independent power producer, Clearway Energy Inc. (NYSE:CWEN), an existing investment partner of Fengate's on an operational wind facility. "This transaction supports our energy transition strategy to acquire core, operating long-term contracted renewable projects for Fengate Infrastructure Yield Fund, and we are proud to partner with Clearway on a second renewables investment," said Greg Calhoun, Managing Director an

    3/31/26 9:00:00 AM ET
    $CWEN
    Electric Utilities: Central
    Utilities

    PDD Holdings Announces Fourth Quarter 2025 and Fiscal Year 2025 Unaudited Financial Results

    DUBLIN and SHANGHAI, March 25, 2026 (GLOBE NEWSWIRE) -- PDD Holdings Inc. ("PDD Holdings" or the "Company") (NASDAQ:PDD), today announced its unaudited financial results for the fourth quarter ended and the fiscal year ended December 31, 2025. Fourth Quarter 2025 Highlights Total revenues in the quarter were RMB123,912.2 million (US$117,719.2 million), an increase of 12% from RMB110,610.1 million in the same quarter of 2024.Operating profit in the quarter was RMB27,719.7 million (US$3,963.9 million), compared with RMB25,592.2 million in the same quarter of 2024. Non-GAAP2 operating profit in the quarter was RMB29,474.1 million (US$4,214.7 million), compared with RMB27,996.5 million in th

    3/25/26 6:30:00 AM ET
    $PDD
    EDP Services
    Technology

    PDD Holdings to Report Fourth Quarter and Fiscal Year 2025 Unaudited Financial Results on March 25, 2026

    DUBLIN and SHANGHAI, March 18, 2026 (GLOBE NEWSWIRE) -- PDD Holdings Inc. ("PDD Holdings" or the "Company") (NASDAQ:PDD) today announced that it will report its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2025, before U.S. markets open on Wednesday, March 25, 2026. The Company's management will hold an earnings conference call at 7:30 AM ET on March 25, 2026 (11:30 AM GMT and 7:30 PM HKT on the same day). The conference call will be webcast live at https://investor.pddholdings.com/investor-events. The webcast will be available for replay at the same website following the conclusion of the call. About PDD Holdings:PDD Holdings is a multinational

    3/18/26 8:05:00 AM ET
    $PDD
    EDP Services
    Technology

    $CG
    $CWEN
    $GDEV
    $LASR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by The Carlyle Group Inc.

    SC 13D/A - Carlyle Group Inc. (0001527166) (Subject)

    11/15/24 5:22:29 PM ET
    $CG
    Investment Managers
    Finance

    Amendment: SEC Form SC 13G/A filed by Avidity Biosciences Inc.

    SC 13G/A - Avidity Biosciences, Inc. (0001599901) (Subject)

    11/14/24 5:46:11 PM ET
    $RNA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Clearway Energy Inc.

    SC 13G/A - Clearway Energy, Inc. (0001567683) (Subject)

    11/14/24 3:00:09 PM ET
    $CWEN
    Electric Utilities: Central
    Utilities